SOLAL
SOLAL® Homocysteine Lowering Formula | Heart & Neurological Health | 30 Capsules
SOLAL® Homocysteine Lowering Formula | Heart & Neurological Health | 30 Capsules
Nappi code: 704934-001
Couldn't load pickup availability
Approved by Experts
Personalised Health
Delivered Nationwide
Solal® Homocysteine Lowering Formula — Supports Heart & Neurological Health — Essential Nutrients
Homocysteine Lowering Formula by SOLAL® delivers a synergistic blend of B vitamins, including folate, riboflavin-5-phosphate, pyridoxal-5-phosphate, and methylcobalamin, alongside inositol and zinc. These vital cofactors are essential for the efficient functioning of the body's methylation cycle. This critical biochemical pathway is responsible for converting the amino acid homocysteine into methionine, a process crucial for cellular health. Maintaining optimal homocysteine levels is directly associated with supporting both cardiovascular and neurological well-being, mitigating risks linked to elevated concentrations of this metabolite.
Recommended Usage
Adults: Take one capsule daily with food.
Composition
| Serving size : 1 capsule | Amount per serving |
| Inositol | 242,5 mg |
| Zinc amino acid chelate | 100,0 mg |
| providing zinc | 20,0 mg |
| Pyridoxal-5-phosphate (vitamin B6) | 68,5 mg |
| Riboflavin-5-phosphate (vitamin B2) | 13,3 mg |
| L-5-methyltetrahydrofolate calcium | 543,0 mcg |
| providing folate | 500,0 mcg |
| Methylcobalamin (vitamin B12) | 98,5 mcg |
Other Ingredients
Magnesium stearate, microcrystalline cellulose and talc
Contains sugar: Inositol 0,25 g/tablet
Does Not Contain
Suitable for vegans and vegetarians
Storage
Store in a cool dry place (<25°C), away from sunlight. Keep out of reach of children.
Product Form
Capsule
Warnings/Contraindications
If pregnant, nursing or taking medication, consult your healthcare practitioner before use.
Do not use this product if you have an allergy or sensitivity to any of the ingredients.
If you are on any medication or suffering from any medical condition, it is advisable to seek medical advice before starting any new medicine, supplement or remedy.
Do not exceed recommended dosage(s) unless on the advice of a healthcare practitioner.
Carbamazepine, lithium and valproic acid reduce the level of inositol in the brain by inhibiting enzymes responsible for inositol production in the brain.
The effect on brain inositol levels may contribute to their effect on bipolar disorder.
The effect of inositol supplementation on their therapeutic effect in bipolar disease is unknown.
Please review package insert (if available) for further information.
